2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Morphine Abuse in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SH; Chiang, YC; Ho, IK; Ho, WJ; Huang, CL; Lane, HY; Ma, WL; Wang, RY; Yang, HT | 1 |
1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Morphine Abuse
Article | Year |
---|---|
Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction.
Topics: Adult; Animals; Cytochrome P-450 CYP2B6; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation; Humans; Male; Methadone; Mice; Mice, Inbred C57BL; Morphine Dependence; Opiate Substitution Treatment; Ovariectomy; Polymorphism, Single Nucleotide; Pyrrolidines; Response Elements; Sex Factors; Signal Transduction; Tamoxifen | 2017 |